C. Randal Mills - Apr 27, 2023 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for C. Randal Mills
Stock symbol
ELUT
Transactions as of
Apr 27, 2023
Transactions value $
$0
Form type
4
Date filed
4/28/2023, 05:31 PM
Previous filing
Jun 23, 2022
Next filing
Jun 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELUT Class A Common Stock Options Exercise $0 +44.9K +1468.38% $0.00 48K Apr 27, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELUT Restricted Stock Units Award $0 +135K $0.00 135K Apr 27, 2023 Class A Common Stock 135K Direct F2, F3
transaction ELUT Restricted Stock Units Options Exercise $0 -44.9K -33.33% $0.00 89.9K Apr 27, 2023 Class A Common Stock 44.9K Direct F2, F3
transaction ELUT Restricted Stock Units Award $0 +89.9K $0.00 89.9K Apr 27, 2023 Class A Common Stock 89.9K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,061 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan.
F2 Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock.
F3 One-third of the shares underlying these restricted stock units are immediately vested. The remaining two-thirds of the underlying shares vest in four equal annual installments on June 21, 2023, June 21, 2024, June 21, 2025 and June 21, 2026.
F4 The restricted stock units vest in four equal installments upon the Issuer's achievement of a per share price equal to or greater than $12.50, $17.00, $25.00 and $37.00 in each case determined based on twenty consecutive days of trading at or above the applicable threshold subject to the Reporting Person's continuous employment with the Issuer through the vesting date.